IMPROVEMENT IN HEREDITARY ANGIOEDEMA DIAGNOSIS: FINDINGS FROM THE ICATIBANT OUTCOME SURVEY

被引:0
|
作者
Zanichelli, A.
Magerl, M.
Longhurst, H.
Aberer, W.
Bygum, A.
Caballero, T.
Bouillet, L.
Grumach, A.
Perrin, A.
Andresen, I.
Maurer, M.
机构
关键词
D O I
暂无
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
O005
引用
收藏
页码:S2 / S3
页数:2
相关论文
共 50 条
  • [41] Icatibant use in Brazilian patients with hereditary angioedema (HAE) type 1 or 2 and HAE with normal C1-INH levels: findings from the Icatibant Outcome Survey Registry Study
    Grumach, Anete S.
    Henriques, Marina T.
    Bardou, Maine L. D.
    Pontarolli, Daniele A.
    Botha, Jaco
    Correa, Mariangela
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2022, 97 (04) : 448 - 457
  • [42] LONGITUDINAL NATURAL HISTORY OF PATIENTS WITH TYPE I/II HEREDITARY ANGIOEDEMA: ICATIBANT OUTCOME SURVEY DATA
    Maurer, M.
    Caballero, T.
    Aberer, W.
    Zanichelli, A.
    Bouillet, L.
    Bygum, A.
    Grumach, A.
    Pommie, C.
    Andresen, I.
    Longhurst, H.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2017, 119 (05) : S42 - S43
  • [43] IN BRIEF Icatibant (Firazyr) for Hereditary Angioedema
    不详
    MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2011, 53 (1378): : 96 - 96
  • [44] Succesful treatment with icatibant for hereditary angioedema
    Almero, R.
    Campos, A.
    Monte, E.
    Diaz, M.
    Calaforra, S.
    Hernandez, D.
    ALLERGY, 2010, 65 : 600 - 601
  • [45] Long-term effectiveness and safety of icatibant for the on-demand treatment of hereditary angioedema attacks: 10 years of the Icatibant Outcome Survey
    Maurer, M.
    Longhurst, H. J.
    Bouillet, L.
    Caballero, T.
    Grumach, A. S.
    Botha, J.
    Andresen, I
    Aberer, W.
    ALLERGY, 2020, 75 : 59 - 60
  • [46] Icatibant in hereditary angioedema: news and challenges
    Bouillet, Laurence
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 267 - 272
  • [47] The effectiveness of Icatibant in the treatment of hereditary angioedema
    Frambach, Y.
    Schumacher, N.
    Grabbe, J.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2008, 6 (10): : 915 - 915
  • [48] Potentially fatal hereditary angioedema: A case of delayed diagnosis treated with icatibant
    Morrone, Pietro
    Spadafora, Santo
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 72 (05) : AB58 - AB58
  • [49] Real-world outcomes in C1 inhibitor hereditary angioedema: experience from the icatibant outcome survey in Spain
    Guilarte, M.
    Sala-Cunill, A.
    Baeza, M. L.
    Cabanas, R.
    Hernandez, M. D.
    Ibanez, E.
    Larramendi, C. H.
    Lleonart, R.
    Lobera, T.
    Marques, L.
    Saenz De San Pedro, B.
    Pommie, C.
    Andresen, I
    Caballero, T.
    ALLERGY, 2017, 72 : 598 - 598
  • [50] The Icatibant Outcome Survey: Characterizing Breakthrough Hereditary Angioedema Attacks In Patients Receiving Long-Term Prophylaxis
    Aberer, Werner
    Maurer, Marcus
    Bouillet, Laurence
    Perrin, Amandine
    Zanichelli, Andrea
    Caballero, Teresa
    Longhurst, Hilary
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2014, 133 (02) : AB35 - AB35